{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:17:58Z","timestamp":1791919078688,"version":"4.3.4"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Spanish Ministry of Economy and Competitiveness","award":["SAF2011-22506"],"award-info":[{"award-number":["SAF2011-22506"]}]},{"name":"Spanish Ministry of Economy and Competitiveness","award":["SAF2011-22855"],"award-info":[{"award-number":["SAF2011-22855"]}]},{"name":"Spanish Ministry of Economy and Competitiveness","award":["BFU2012-39092-C02-01"],"award-info":[{"award-number":["BFU2012-39092-C02-01"]}]},{"name":"Spanish Ministry of Economy and Competitiveness","award":["SAF2014-56197-R"],"award-info":[{"award-number":["SAF2014-56197-R"]}]},{"name":"Fundaci\u00f3 Gent per Gent","award":["19-NEURO"],"award-info":[{"award-number":["19-NEURO"]}]},{"name":"Asociaci\u00f3n Valenciana de Enfermedad de Huntington"},{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"crossref","award":["Prometeo\/2012\/005"],"award-info":[{"award-number":["Prometeo\/2012\/005"]}],"id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"crossref","award":["ISIC\/2012\/009"],"award-info":[{"award-number":["ISIC\/2012\/009"]}],"id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"crossref","award":["Prometeo\/2014\/011"],"award-info":[{"award-number":["Prometeo\/2014\/011"]}],"id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004895","name":"Fondo Social Europeo","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.nbd.2016.02.004","type":"journal-article","created":{"date-parts":[[2016,2,3]],"date-time":"2016-02-03T03:18:51Z","timestamp":1454469531000},"page":"190-201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Specific promoter deacetylation of histone H3 is conserved across mouse models of Huntington's disease in the absence of bulk changes"],"prefix":"10.1016","volume":"89","author":[{"given":"Deisy","family":"Guiretti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Sempere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose P.","family":"Lopez-Atalaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Ferrer-Montiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"Barco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis M.","family":"Valor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2016.02.004_bb0005","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1093\/hmg\/ddv099","article-title":"Neuronal identity genes regulated by super-enhancers are preferentially down-regulated in the striatum of Huntington's disease mice","volume":"24","author":"Achour","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2016.02.004_bb0010","doi-asserted-by":"crossref","first-page":"18237","DOI":"10.1523\/JNEUROSCI.4554-11.2011","article-title":"cAMP response element-binding protein is a primary hub of activity-driven neuronal gene expression","volume":"31","author":"Benito","year":"2011","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.nbd.2016.02.004_bb0015","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1002\/jnr.22252","article-title":"Fear learning and extinction are linked to neuronal plasticity through Rin1 signaling","volume":"88","author":"Bliss","year":"2010","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2016.02.004_bb0020","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1038\/npp.2011.128","article-title":"Combined treatment with the mood stabilizers lithium and valproate produces multiple beneficial effects in transgenic mouse models of Huntington's disease","volume":"36","author":"Chiu","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.nbd.2016.02.004_bb0025","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.mcn.2011.11.003","article-title":"Suppression of aggregate formation of mutant huntingtin potentiates CREB-binding protein sequestration and apoptotic cell death","volume":"49","author":"Choi","year":"2012","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.nbd.2016.02.004_bb0030","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1128\/MCB.00607-10","article-title":"Plk5, a polo box domain-only protein with specific roles in neuron differentiation and glioblastoma suppression","volume":"31","author":"de Carcer","year":"2011","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.nbd.2016.02.004_bb0035","doi-asserted-by":"crossref","first-page":"12539","DOI":"10.1073\/pnas.0801174105","article-title":"The Rab5 guanylate exchange factor Rin1 regulates endocytosis of the EphA4 receptor in mature excitatory neurons","volume":"105","author":"Deininger","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2016.02.004_bb0040","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1523\/JNEUROSCI.23-03-00748.2003","article-title":"The RAS effector RIN1 modulates the formation of aversive memories","volume":"23","author":"Dhaka","year":"2003","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.nbd.2016.02.004_bb0045","doi-asserted-by":"crossref","first-page":"9418","DOI":"10.1523\/JNEUROSCI.23-28-09418.2003","article-title":"Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice","volume":"23","author":"Ferrante","year":"2003","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.nbd.2016.02.004_bb0050","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1523\/JNEUROSCI.5203-05.2006","article-title":"Development of the deep cerebellar nuclei: transcription factors and cell migration from the rhombic lip","volume":"26","author":"Fink","year":"2006","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.nbd.2016.02.004_bb0055","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1471-213X-7-103","article-title":"Gene delivery into mouse retinal ganglion cells by in utero electroporation","volume":"7","author":"Garcia-Frigola","year":"2007","journal-title":"BMC Dev. Biol."},{"key":"10.1016\/j.nbd.2016.02.004_bb0060","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1074\/jbc.M410210200","article-title":"Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease","volume":"280","author":"Gardian","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2016.02.004_bb0065","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jneumeth.2007.09.023","article-title":"Dual-promoter lentiviral vectors for constitutive and regulated gene expression in neurons","volume":"168","author":"Gascon","year":"2008","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.nbd.2016.02.004_bb0070","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1073\/pnas.0711257105","article-title":"The insulin-like growth factor pathway is altered in spinocerebellar ataxia type 1 and type 7","volume":"105","author":"Gatchel","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2016.02.004_bb0075","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/hmg\/ddr552","article-title":"Long-term memory deficits in Huntington's disease are associated with reduced CBP histone acetylase activity","volume":"21","author":"Giralt","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2016.02.004_bb0080","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1073\/pnas.0437870100","article-title":"Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease","volume":"100","author":"Hockly","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2016.02.004_bb0085","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/hmg\/ddl013","article-title":"Regional and cellular gene expression changes in human Huntington's disease brain","volume":"15","author":"Hodges","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2016.02.004_bb0090","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group","volume":"72","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2016.02.004_bb0095","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/00001756-200303240-00007","article-title":"Inducible PC12 cell model of Huntington's disease shows toxicity and decreased histone acetylation","volume":"14","author":"Igarashi","year":"2003","journal-title":"Neuroreport"},{"key":"10.1016\/j.nbd.2016.02.004_bb0100","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/dvdy.24090","article-title":"Conditional ablation of Tbr2 results in abnormal development of the olfactory bulbs and subventricular zone-rostral migratory stream","volume":"243","author":"Kahoud","year":"2014","journal-title":"Developmental Dynamics"},{"key":"10.1016\/j.nbd.2016.02.004_bb0105","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/NEN.0b013e3181d6c436","article-title":"Partial depletion of CREB-binding protein reduces life expectancy in a mouse model of Huntington disease","volume":"69","author":"Klevytska","year":"2010","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2016.02.004_bb0110","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2007.02.005","article-title":"Chromatin modifications and their function","volume":"128","author":"Kouzarides","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2016.02.004_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024620","article-title":"d-beta-hydroxybutyrate is protective in mouse models of Huntington's disease","volume":"6","author":"Lim","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2016.02.004_bb0120","doi-asserted-by":"crossref","first-page":"13909","DOI":"10.1523\/JNEUROSCI.3850-07.2007","article-title":"cAMP response element-binding protein-mediated gene expression increases the intrinsic excitability of CA1 pyramidal neurons","volume":"27","author":"Lopez de Armentia","year":"2007","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.nbd.2016.02.004_bb0125","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.tig.2014.09.003","article-title":"Can changes in histone acetylation contribute to memory formation?","volume":"30","author":"Lopez-Atalaya","year":"2014","journal-title":"Trends in genetics: TIG"},{"key":"10.1016\/j.nbd.2016.02.004_bb0130","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1038\/emboj.2011.299","article-title":"CBP is required for environmental enrichment-induced neurogenesis and cognitive enhancement","volume":"30","author":"Lopez-Atalaya","year":"2011","journal-title":"EMBO J."},{"key":"10.1016\/j.nbd.2016.02.004_bb0135","doi-asserted-by":"crossref","first-page":"8072","DOI":"10.1093\/nar\/gkt590","article-title":"Genomic targets, and histone acetylation and gene expression profiling of neural HDAC inhibition","volume":"41","author":"Lopez-Atalaya","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.nbd.2016.02.004_bb0140","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2016.02.004_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041423","article-title":"Genome-wide histone acetylation is altered in a transgenic mouse model of Huntington's disease","volume":"7","author":"McFarland","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2016.02.004_bb0150","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000109853","article-title":"How neuronal migration contributes to the morphogenesis of the CNS: insights from the zebrafish","volume":"30","author":"Mione","year":"2008","journal-title":"Dev. Neurosci."},{"key":"10.1016\/j.nbd.2016.02.004_bb0155","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.nbd.2014.11.023","article-title":"Increased acetyl and total histone levels in post-mortem Alzheimer's disease brain","volume":"74","author":"Narayan","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2016.02.004_bb0160","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/ajmg.a.33911","article-title":"Juvenile Huntington disease in an 18-month-old boy revealed by global developmental delay and reduced cerebellar volume","volume":"155A","author":"Nicolas","year":"2011","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.nbd.2016.02.004_bb0165","doi-asserted-by":"crossref","first-page":"11174","DOI":"10.1523\/JNEUROSCI.3004-06.2006","article-title":"Mitochondrial-dependent Ca2+ handling in Huntington's disease striatal cells: effect of histone deacetylase inhibitors","volume":"26","author":"Oliveira","year":"2006","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.nbd.2016.02.004_bb0170","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1146\/annurev.neuro.29.051605.113042","article-title":"Trinucleotide repeat disorders","volume":"30","author":"Orr","year":"2007","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2016.02.004_bb0175","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1101\/lm.029363.112","article-title":"Histone H3 lysine methylation in cognition and intellectual disability disorders","volume":"20","author":"Parkel","year":"2013","journal-title":"Learn. Mem."},{"key":"10.1016\/j.nbd.2016.02.004_bb0180","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.toxlet.2014.08.010","article-title":"Insulin-like growth factor binding protein 5 (IGFBP5) mediates methamphetamine-induced dopaminergic neuron apoptosis","volume":"230","author":"Qiao","year":"2014","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.nbd.2016.02.004_bb0185","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/hmg\/ddm078","article-title":"Histones associated with downregulated genes are hypo-acetylated in Huntington's disease models","volume":"16","author":"Sadri-Vakili","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2016.02.004_bb0190","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1038\/npp.2009.125","article-title":"Selective boosting of transcriptional and behavioral responses to drugs of abuse by histone deacetylase inhibition","volume":"34","author":"Sanchis-Segura","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.nbd.2016.02.004_bb0195","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nature01080","article-title":"Active genes are tri-methylated at K4 of histone H3","volume":"419","author":"Santos-Rosa","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2016.02.004_bb0200","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/sj.gt.3301731","article-title":"Titering lentiviral vectors: comparison of DNA, RNA and marker expression methods","volume":"9","author":"Sastry","year":"2002","journal-title":"Gene Ther."},{"key":"10.1016\/j.nbd.2016.02.004_bb0205","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/8.3.397","article-title":"Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin","volume":"8","author":"Schilling","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2016.02.004_bb0210","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00431-004-1537-3","article-title":"Early onset Huntington disease: a neuronal degeneration syndrome","volume":"163","author":"Seneca","year":"2004","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.nbd.2016.02.004_bb0215","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","article-title":"Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease","volume":"12","author":"Slow","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2016.02.004_bb0220","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1093\/hmg\/ddm064","article-title":"Modulation of nucleosome dynamics in Huntington's disease","volume":"16","author":"Stack","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2016.02.004_bb0225","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/35099568","article-title":"Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila","volume":"413","author":"Steffan","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2016.02.004_bb0230","doi-asserted-by":"crossref","first-page":"15564","DOI":"10.1073\/pnas.0804249105","article-title":"The HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington's disease transgenic mice","volume":"105","author":"Thomas","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2016.02.004_bb0235","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s12035-014-8715-8","article-title":"Transcription, epigenetics and ameliorative strategies in Huntington's disease: a genome-wide perspective","volume":"51","author":"Valor","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.nbd.2016.02.004_bb0240","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.neuropharm.2013.10.025","article-title":"What's wrong with epigenetics in Huntington's disease?","volume":"80","author":"Valor","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2016.02.004_bb0245","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1523\/JNEUROSCI.4737-10.2011","article-title":"Ablation of CBP in forebrain principal neurons causes modest memory and transcriptional defects and a dramatic reduction of histone acetylation but does not affect cell viability","volume":"31","author":"Valor","year":"2011","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.nbd.2016.02.004_bb0250","doi-asserted-by":"crossref","first-page":"10471","DOI":"10.1523\/JNEUROSCI.0670-13.2013","article-title":"Genomic landscape of transcriptional and epigenetic dysregulation in early onset polyglutamine disease","volume":"33","author":"Valor","year":"2013","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.nbd.2016.02.004_bb0255","doi-asserted-by":"crossref","first-page":"E3027","DOI":"10.1073\/pnas.1311323110","article-title":"Targeting H3K4 trimethylation in Huntington disease","volume":"110","author":"Vashishtha","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2016.02.004_bb0260","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.nbd.2009.10.001","article-title":"Syndromic features and mild cognitive impairment in mice with genetic reduction on p300 activity: differential contribution of p300 and CBP to Rubinstein\u2013Taybi syndrome etiology","volume":"37","author":"Viosca","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2016.02.004_bb0265","doi-asserted-by":"crossref","first-page":"19831","DOI":"10.1074\/jbc.M001475200","article-title":"Inhibiting caspase cleavage of huntingtin reduces toxicity and aggregate formation in neuronal and nonneuronal cells","volume":"275","author":"Wellington","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2016.02.004_bb0270","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1093\/hmg\/10.17.1829","article-title":"Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington's disease","volume":"10","author":"Wyttenbach","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2016.02.004_bb0275","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/jnr.20490","article-title":"Insulin-like growth factor-I protects granule neurons from apoptosis and improves ataxia in weaver mice","volume":"80","author":"Zhong","year":"2005","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2016.02.004_bb0280","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1152\/physrev.00041.2009","article-title":"Molecular mechanisms and potential therapeutical targets in Huntington's disease","volume":"90","author":"Zuccato","year":"2010","journal-title":"Physiol. Rev."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996116300250?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996116300250?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:10:27Z","timestamp":1760850627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996116300250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":56,"alternative-id":["S0969996116300250"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2016.02.004","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Specific promoter deacetylation of histone H3 is conserved across mouse models of Huntington's disease in the absence of bulk changes","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2016.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}